SEC Filings | PLx Pharma Inc.

Filing date	Form	Description	Filing Group	View
11/08/19	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	View HTML 0001437749-19-022041.pdf 0001437749-19-022041.rtf 0001437749-19-022041.xls EX-101.INS - XBRL INSTANCE DOCUMENT
11/08/19	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001193805-19-001403.pdf 0001193805-19-001403.rtf 0001193805-19-001403.xls
08/19/19	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0000921895-19-002283.pdf 0000921895-19-002283.rtf 0000921895-19-002283.xls
08/09/19	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	View HTML 0001437749-19-016122.pdf 0001437749-19-016122.rtf 0001437749-19-016122.xls EX-101.INS - XBRL INSTANCE DOCUMENT
07/02/19	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Proxy Filings	View HTML 0000921895-19-001952.pdf 0000921895-19-001952.rtf 0000921895-19-001952.xls
05/21/19	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000921895-19-001594.pdf 0000921895-19-001594.rtf
05/10/19	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	View HTML 0001437749-19-009360.pdf 0001437749-19-009360.rtf 0001437749-19-009360.xls EX-101.INS - XBRL INSTANCE DOCUMENT
04/04/19	EFFECT	EFFECT	Other	View HTML 9999999995-19-000610.pdf 9999999995-19-000610.rtf
04/04/19	EFFECT	EFFECT	Other	View HTML 9999999995-19-000607.pdf 9999999995-19-000607.rtf
04/02/19	10-K/A	Amendment to a previously filed 10-K	Annual Filings	View HTML 0001437749-19-006284.pdf 0001437749-19-006284.rtf 0001437749-19-006284.xls